Khazanah Nasional Berhad, the sovereign wealth fund of Malaysia, has filed a Form 13F-HR with the U.S. Securities and Exchange Commission disclosing its equity portfolio as of December 31, 2022. The filing, signed by Chief Investment Officer Mohamad Hishammudin bin Hamdan, reports a total value of approximately $1.67 billion for the U.S. equity securities held.
The portfolio consists of 10 distinct positions, with the largest holding being the iShares Core MSCI Europe ETF. Khazanah holds 28,977,043 shares of this fund, valued at $610,043,000. The second-largest position is the Vanguard Index Funds S&P 500 ETF Shares, which accounts for 697,477 shares valued at $245,051,569.
Khazanah also holds significant stakes in several individual companies. The fund owns 100,280,731 shares of the iShares Core S&P 500 ETF, valued at $261,005,000. Additionally, the fund holds 337,000 shares of Ke Holdings Inc. Sponsored ADS, valued at $4,704,520, and 152,000 shares of Pinduoduo Inc. Sponsored ADS, valued at $12,395,600.
The filing lists a total of 10 positions, including Rapid Micro Biosystems Inc. Class A Common Stock, which is held in a Defined Benefit Plan, with 648,905 shares valued at $733,263. The remaining positions include the iShares Core S&P 500 ETF and the iShares Core MSCI Europe ETF, which are held in the Defined Benefit Plan.
